Hikma Pharmaceuticals PLC (HKMPY)
OTCMKTS
· Delayed Price · Currency is USD
51.25
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of $5.57 billion as of April 24, 2025. Its market cap has increased by 10.50% in one year.
Market Cap
5.57B
Enterprise Value
6.75B
Revenue
3.13B
Ranking
n/a
PE Ratio
15.53
Stock Price
$51.25
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 833.84M to 5.57B, an increase of 568.55%. That is a compound annual growth rate of 10.24%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 1.71B |
| Endo Inc. | 1.62B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 721.11M |
| Northwest Biotherapeutics | 608.87M |
| Elite Pharmaceuticals | 427.31M |
| Glass House Brands | 402.04M |
| CytoDyn | 279.15M |